NC
MRK icon

nVerses Capital’s Merck MRK Stock Holding History

nVerses Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Buy
+3,139
New +$367K 0.62% 16
2024
Q4 		– Sell
-400
Closed -$45.4K – 540
2024
Q3 		$45.4K Sell
400
-2,200
-85% -$261K 0.02% 659
2024
Q2 		$322K Buy
2,600
+2,100
+420% +$271K 0.19% 174
2024
Q1 		$66K Buy
+500
New +$61.6K 0.16% 229

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

nVerses Capital's MRK Position: Q2 2026 in Review

nVerses Capital opened a new position in Merck (MRK) in Q2 2026: 3,139 shares worth $403K. The stake represents 0.62% of the portfolio and ranks #16 among its holdings. This is a return to the name: nVerses Capital previously reported a position in MRK as recently as Q3 2024.

nVerses Capital first reported a position in MRK in Q1 2024 and has held it in 4 quarters since. 3,851 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • nVerses Capital held 3,139 shares of Merck worth $403K as of Q2 2026.
  • Merck was a new nVerses Capital position in Q2 2026.
  • Merck made up 0.62% of nVerses Capital's portfolio in Q2 2026, its #16 holding.
  • nVerses Capital first reported a position in Merck in Q1 2024 and has held it in 4 quarters since.
  • 3,851 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.